Clinical Trial Update: To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the pharmacokinetics and pharmacodynamics of a single dose of AZD1656 when co-administered with gemfibrozil in individu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656
• Gemfibrozil (Gemfibrozil)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED